Abstract
Class B G protein-coupled receptors (GPCRs) comprise a family of 15 peptide-binding members, which are crucial targets for endocrine, metabolic, and stress-related disorders. While their protein structures and dynamics remain largely unclear, computer modeling and simulations represent a promising means to help solve such puzzles. Herein, we present a basic introduction to the methodology of molecular dynamics (MD) simulations and two analytical methods to assess the conformational ensembles and transitions of Class B GPCRs, using our recent studies of the human pituitary adenylate cyclase activating polypeptide (PAC1) receptor as an example. From long MD simulations, conformational ensembles with different roles in ligand binding and receptor activation are sampled to establish four states identified as either “open” or “closed” for the PAC1 receptor. Next, the dynamical network can be applied to analyze the simulations and identify key features within each conformational ensemble, which help distinguish the ligand-bound states of the PAC1 receptor from the ligand-free one. Further, the Markov State Model has emerged as a key approach to construct the transition network and connect the GPCR ensembles, providing detailed information for the transition pathways and kinetics. For the ligand-free PAC1 receptor, the transitions within the closed states are near 10–30 times faster than the open-closed transitions, which is likely related to the activation mechanism of the receptor. Overall, long MD simulations and analyses are useful to assess conformational transitions for the Class B GPCRs and to gain mechanistic insight, which is difficult to obtain using other methods.
Keywords: Multiscale modeling, Molecular dynamics, Conformational ensemble, Markov state model, Communication networks
1. Introduction
G protein-coupled receptors (GPCRs), the largest family of trans-membrane proteins in the human genome, transduce a variety of signals, including hormones, neurotransmitters, odorants, tastants, and light, to regulate virtually all physiological responses for homeostasis [1, 2]. The more than 800 canonical heptahelical receptors are divided into 5 major classes based on sequence and structural similarities: rhodopsin (Class A); secretin (Class B); glutamate (Class C); adhesion and frizzled/taste. Class A is the largest class of more than 700 members with ~40 unique structures available. With just 15 members, the Class B secretin/glucagon/VIP family of GPCRs is critically important with respect to neural development, body calcium homeostasis, glucose metabolism, circadian rhythm, thermoregulation, inflammation, feeding behavior, pain modulation, stress and related endocrine responses [3–5]. Accordingly, these receptors are pharmacological targets for a variety of disorders including osteoporosis, hypercalcemia, type 2 diabetes, obesity, migraine and related chronic pain disorders, anxiety and depression. Despite the great pharmacological interests, only two full-length Class B receptor structures [6–8] have been determined. The three-dimensional molecular structures remain entirely or partially elusive among most Class B members. As a result, the detailed knowledge of receptor activation and regulation, such as the transitions among various states, is still incomplete. Therefore, for insight into ligand selectivity, activation, and regulation mechanisms, it is crucial to apply computer modeling to study the conformational states, as well as the associated transition pathways. Such insight will also serve as the foundation to design structure- and mechanism-based strategies to modulate Class B GPCRs.
Class B GPCRs are activated by well-studied peptide hormones, such as corticotropin-releasing factor (CRF), calcitonin gene-related peptide (CGRP), glucagon, glucagon-like peptide (GLP), pituitary adenylate cyclase activating polypeptide (PACAP), parathyroid hormone (PTH), secretin, and vasoactive intestinal peptide (VIP). The functional states are associated with distinct protein conformations as well as the presence of various ligands. One of the major challenges in studying the conformational transitions of Class B receptors is capturing the dynamics of the full-length receptor structure to accurately simulate the two-domain binding model for receptor activation [9]. In contrast to Class A GPCRs, which contain only the heptahelical transmembrane domain (7TM), each Class B receptor possesses an additional extracellular domain (ECD) of ~120 amino acid residues that is crucial for high affinity peptide binding and dynamics that allow bound-ligand presentation to the 7TM for receptor activation. Given such structural complexity, the choreography of Class B receptor activation—induced by the neuropeptide—is likely different from that of Class A receptors.
Although only few are available in full-length structures in Class B family, e.g. the glucagon receptor (GCGR, PDBIDs: 5XEZ and 5YQZ) and glucagon-like peptide 1 receptor (GLP-1R, PDBID: 5NX2), the construction of full-length models of other Class B receptors is viable with current knowledge of the 7TM and ECD structures. The 7TM structures of four members had been determined between 2013 and mid-2018: GCGR (PDBIDs: 5XEZ, 5YQZ, 5EE7, and 4L6R), corticotropin-releasing factor receptor (CRF1R, PDBID: 4K5Y), GLP-1R (PDBIDs: 5NX2, 5VAI, 5VEW, and 5VEX), and calcitonin receptor (PDBID: 5UZ7). The ECD structures of nine members are known: glucose-dependent insulinotropic polypeptide (GIP) receptor (PDBID: 2QKH), GCGR (PDBIDs: 4ERS and 4LF3), GLP-1R (PDBIDs: 3IOL, 5E94, 3C59, 3C5T, and 4ZGM), PACAP receptor type 1 (PAC1R, PDBIDs: 2JOD and 3N94), VIP/PACAP receptor type 2 (VPAC2R, PDBID: 2X57), PTH1 receptor (PDBIDs: 3CM4 and 3H3G), CRF1R (PDBIDs: 2L27, 3EHS, and 3EHU), CRF2R (PDBIDs: 1U34 and 3N96), and CGRP receptor (PDBIDs: 3N7P, 3N7R, and 3N7S). These experimental efforts allow the exploration of function-related conformational states and the assessment of transitions among these states via protein modeling and molecular dynamics (MD) simulations. Under physiological conditions, GPCRs are not static and often transition fluidly and fleetingly from one conformation to another, forming ensembles of receptor microstates that kinetically constitute macrostates. These constitutive macrostates may respond to binding of specific ligands and allosteric modulators or preferentially favor particular signaling events. Thus, long MD simulations (conventional or with enhanced sampling) followed by structural-based analysis are suitable to sample and distinguish these states, as well as to identify their transitions.
However, despite the large body of simulation studies of Class A GPCRs [10–16], the growth of MD simulations to investigate Class B GPCRs (with the full-length or 7TM models) has only emerged recently, due to the increasing amount of 7TM crystal structures. These simulation studies range from a few hundred nanoseconds to tens of microseconds and have provided valuable information regarding the molecular basis of receptor dynamics [17, 18], stabilizing effects from point mutations [19], hydrogen bonding network at an allosteric site [20], and inactive-to-active transitions focusing on TM displacement [21, 22]. Often in good agreement with experimental evidence, these recent studies provide invaluable mechanistic insight, which is typically costly and lengthy to study using experimental approaches alone. With advances in high-performance computing (HPC) [23, 24] and multiscale modeling technology [16, 17, 24–27], MD simulations have become useful tools to explore more complex systems (i.e., Class B GPCRs in the oligomeric states, the ligand-bound states, or the G protein/arrestin-bound states) on biologically relevant timescales. In this chapter, we provide a basic introduction to the methodology of MD simulation and the analysis to study conformational transitions of Class B GPCRs involving large-scale domain motions and helical displacements, using our studies of the PAC1 receptor as an example.
2. Methods
2.1. Description of the MD Protocol
2.1.1. Conventional MD Simulations
An MD simulation describes the motion of a collection of molecules over time in a system of interest according to the physical and chemical principles. Such a system often contains essential chemical/biological components (such as proteins, water, lipids, and ions) in a three-dimensional box at a condition to mimic real-world experiments (such as temperature and external pressure). Generally, in an all-atom model, each atom is represented by a particle at a specific position in the simulation box with periodic boundary conditions, while the covalent bonds are treated like springs. The interactions between particles are described by equations and parameters—the so-called force field. According to the Newton’s laws, the particle motions are calculated in discrete time steps analogous to the film frames in a movie. The positions of atoms are updated from one step to the next; in a continuous fashion, as atoms move and time advances, a cinematic feature is constructed to show the conformational changes or transitions in the simulation box. In real practice, the time step for biological simulations is often chosen to be around 1 to 2 femtoseconds (fs). Therefore, for a typical simulation of 100 nanoseconds (ns), the number of steps approximates a million for over ten thousand atoms in the system; multiple simulation trajectories (or replicas) are needed for each model construct to ensure reliable data collection. With such high computational demands, MD simulations (i.e., for GPCRs) often require supercomputing resources.
In one of our studies of the PAC1 receptor, for example, each model system contains a PAC1 receptor model, a lipid bilayer of ~219 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) molecules, ~28,500 TIP3P water molecules, counter ions, and 0.15 M NaCl, totaling ~126,000 atoms in a periodic box of 95 × 95 × 134Å3. All the simulations were performed with CHARMM36-cmap force field on the specialized Anton supercomputer using the Anton software 2.13.0 [23, 28]. Microsecond-long MD simulations (2–2.9 μs) for four conformational states were performed in an NPT ensemble (310 K, 1 bar, Berendesn thermostat and semi-isotropic barostat) with a time step of 2 fs (see Note 1).
2.1.2. Preparation of the Starting GPCR Models
The conformational transition between two states of biomolecules, initial state (A) and final state (B), is often under thermodynamic (downhill energy profile) and/or kinetic control (uphill energy profile) [29]. For systems where the probability of reaching B is very low, a strategy is to start with multiple intermediate points which may proceed to A or B while their early conformational evolutions can structurally overlap within a certain range (initial region). Our current class B GPCR study [17] indicated that in a microsecond-long MD simulation, the dynamic free-swinging process of the ECD, exposed to the solution, occurred during the first few hundred nanoseconds, after which the ECD interacted with the extracellular loops (ECLs) of the 7TM to greatly restrict its mobility. The large-scale domain motions lead to different ECD orientations with slight positional variations at the ECD–7TM interface. Thus, it is appropriate to choose initial conformations that have ECD free of interactions with ECLs and of different orientations relative to 7TM to initiate the conformational sampling. Notably, these starting conformations are likely metastable, and thus require them to be well equilibrated in short MD simulations. In our preparation of the PAC1 receptor models, four homology models, differing in the ECD orientations by dihedral rotation at the linker region, were generated from multiple short MD simulations for microsecond-long production simulations [17]. Additionally, the initial models can also be generated using enhanced sampling methods, such as replica exchange [30], adaptive tempering [31], steered MD [32], and accelerated MD [33]. In particular, these methods can accelerate a kinetic-control process, for example, the transition from inactive to active receptor states and vice versa involving the displacement of the intracellular structures related to transmembrane helix 6 (TM6) [21, 22].
2.2. Analytical Methods for Conformational Transitions
While MD simulations provide direct visualization of GPCR conformations and conformational changes, the rich detail of atom positions also allows qualitative and quantitative characterizations of each conformational state and the transition from one state to another. For example, from four microsecond-long MD simulations [17], we obtained two major conformations distinct in the ECD orientations as the closed (G1, G2, and G3) or open (G4) states (Fig. 1), which implicate differential roles in ligand binding and receptor activation. Herein, we introduce two typical methods to analyze the conformational ensembles of Class B GPCRs and their transitions.
2.2.1. Dynamical Network Analysis
Given the conformational ensembles of variant ECD orientations, analysis of the dynamical network has been applied to identify the shared features of interactions and communication within the ligand-free PAC1 receptor (G1, G2, G3, and G4), in comparison with a trajectory in the ligand-bound state. Such analysis can be readily carried out with the Network View plugin [34–36] in the VMD program [37]. Dynamical networks were created from the last 150 ns of each trajectory. To define the dynamical network, each Cα atom of amino acid residues represents a node; two nodes are connected by an edge if any two of their heavy atoms are within4.5Å for more than 75% of the simulation time [36]. The edge distances dij are derived from the pairwise correlations (Cij) calculated by the program Carma v1.3 [38]. The community substructure of the network is obtained by the Girvan–Newman algorithm [39]. With correlation-based weights, communities correspond to sets of residues that move in concert with each other. The connections between nodes (representing amino acid residues) within one community should be stronger than the connections between nodes across different communities.
TM6 and the third intracellular loop (ICL3) play an essential role in the signaling process of GPCRs—by facilitating the binding of G proteins or other effector proteins at the intracellular receptor face after an outward conformational shift of the TM6/ICL3 segments (in the active state) [11]. The community decompositions of TM6 with weighted edges are displayed in Fig. 1 for four ligand-free states of the PAC1 receptor, in comparison with a ligand-bound state. In the ligand-free G1, G3, and G4 states of the PAC1 receptor, TM6 can be divided into two communities with its extracellular half (Fig. 1, purple) merging into communities containing TM3 or TM7. In G2, although the entire TM6 lies in the same community, it also joins the community containing the intracellular half of TM3. Thus, in all ECD open or closed ligand-free states, TM6 can be separated into two communities and exhibits topological dependency with adjacent TM helices (stronger correlations). By contrast, in the agonist-bound state, the entire length of TM6 behaves as a single community together with the intracellular half of TM5 and fewer correlations with TM3. The stronger communication within TM6 in the agonist-bound state may associate with signal propagation from the agonist-bound orthosteric pocket to the intracellular G protein-binding site. In direct terms, with fewer correlations with other neighboring TM helices, the single TM6 community permits an easier outward shift of the helix for the conformational changes necessary at the intracellular receptor face for G protein coupling and signaling.
2.2.2. Markov State Models
By applying the analysis based on the Markov State Model (MSM) to the extensive MD trajectory datasets, we have revealed the microsecond to millisecond-scale dynamics between open and closed PAC1 receptor conformations, interconnected within an ensemble of transitional states—timescales toward GPCR activation. The open-to-closed transition, together with the intrinsic features of the receptor, can provide important insight into signaling mechanisms and potential druggable sites. In the following, we describe the general concept and implementation of MSM, our construction and validation of MSM, and our transition paths and timescales among the PAC1 receptor ECD open and closed states.
We used the program MSMBuilder 3.2.0 [40, 41] to build a reversible MSM (see Note 2 for examples of execution). An MSM contains a set of state definitions and a transition matrix characterizing the kinetics on this state space. MSM can model long-time scale kinetics from much shorter trajectories by efficiently sampling transitions between these metastable states [42–45]. For MD simulations, the MSM approach first transforms a collection of MD trajectories into a discrete set of S = {1, …, m} microstates in the conformation space. A m × m transition matrix T(τ) is computed, where each element Tij measures the probability of system going from one microstate (i) to another (j) within an observation time interval τ (lag time), by . Here, cij counts the number of times the system traverses from i to j at time τ. At timescales slightly longer than the microstate lag time, i.e. 2τ, …, nτ, the transition counts become less between microstates and fewer microstates are kinetically connected in a transition matrix. For a Markov process, the vector of probabilities of the system to be in any of its microstate at time (nτ) must meet the Chapman–Kolmogorov equation [42, 46].
(1) |
1. Dataset preparation.
First, we prepared all trajectories using the Cα coordinates of residues 30–419 in the PAC1 receptor, as the Cα atoms are often used to represent the overall protein structure. The first five and the last five amino acid residues were excluded, because they are highly dynamic in the N- and C-termini. The time evolutions of the receptor structures show that each PAC1 receptor model reached a relatively stable structure after 200–500 ns; continuous structure relaxation improved the stability for another 1.5–2.5 μs (Fig. 2b). The last 1.5–2.5 μs of each microsecond simulation with stable final conformations were not included in building an MSM (see Note 3). Hence, the collected six shorter MD simulations of 20–50 ns each, and the first 200–550 ns of the microsecond long simulations, totaling 6324 configurations were used to build the MSM.
2. Clustering.
Next, the MD trajectories were transformed into a dataset of microstates based on structural similarities. We used the k-centers algorithm [40] to group the dataset into 55 clusters by RMSD metric with a mean distance of ~0.34Å and a maximum distance of ~0.56Å, which were within the range of the RMSD standard deviations of the last ~1.5 μs in Fig. 2b. The small cluster number, different from the hundreds to thousands of intrinsic conformations of previous protein folding/unfolding studies [47, 48], is the result of limited conformational changes like the ECD rotation around the melting linker.
3. Lumping and validation.
A series of transition matrices in the evolution of the observation interval (lag time) at τ, 2τ, …, nτ were constructed using maximum likelihood estimation. As the lag time is increased, fewer microstates are kinetically relevant (kinetically reach each other on timescales faster than the lag time) [49]. Thus, those kinetically relevant microstates can be lumped into macrostates (larger and coarser grained) using the Perron-Cluster Cluster Analysis (PCCA) method [50]. Validation was carried out to examine if the model at lag time = τ appears Markovian with increasing lag time = 2τ, …, nτ using both implied timescales and the Chapman–Kolmogorov test [46]. If the macrostate partitions were less robust along implied timescales or if the Markov model errors between the true probability density at time nτ and the probability density predicted by the Markov model at the same time were large, then a refinement of the partition [46] or an improvement of the initial dataset [49] would be necessary.
4. Implied timescales.
The implied timescales as a function of the lag time and the eigenvalues of the transition matrix are shown in Fig. 3. Four macrostates were selected, given the number of the major gaps of the implied timescales as well as the number of eigenvalues of the transition matrix that were close to 1 [50]. For a transition matrix of microstates, the partition of four macrostates was calculated from the eigenfunction structure using PCCA [50]. Consistently, the conformations of G1, G2, G3, and G4 were lumped into the four macrostates, labeled as A, B, C, and D, respectively.
5. Chapman–Kolmogorov test.
In general, given a set of states A that contains either an individual microstate or set of micro-states, we compared the true probability density of T(nτ) based on the transition counts (known as observed trajectory) and the probability density predicted by [T(τ)]n [46, 48]. The initial stationary distribution at time τ restricted to a set A is given by
(2) |
where π is the stationary probability of the m × m transition matrix T(τ). The trajectory-based time-dependence of the probability after time nτ with starting distribution wA is given by
(3) |
where pMD(i, A; nτ) is the trajectory-based estimate of the stochastic transition function given by
(4) |
where is the number of transition counts between states i and j at time nτ. Likewise, the probability to be at A by the Markov model is given by
(5) |
We tested how well the equality pMD(A, A; nτ) = pMSM(A, A; nτ) holds, as whether the solid line is within the error bar range of the dash line in Fig. 4. The uncertainties of the transition probabilities estimated from the MD trajectories are computed as:
(6) |
There are around 27 microstates that constitute the shortest and second shortest transition pathways between the closed and open states; they are identified as four subsets based on the macrostate division. The Chapman–Kolmogorov test of the four subsets is shown in Fig. 4, all of which ensure the test within statistical uncertainty. The transition probabilities from MSM agree well with the probabilities in observed trajectory within statistical uncertainty at a lag time of 1.68 ns. Thus, we built a four-macrostate MSM with 94% data in use with the lag time of 1.68 ns.
We used transition path theory (TPT) [48, 51–53] to calculate the minimum transition net flux of the shortest pathway connecting the ECD closed states or from the ECD open states to the closed states in the transition matrix. For state space S = {1, …, m}, we define the source set A, the target set B, and the intermediate set I. The rate of transitions observed from A → B per τ (time unit) is given by:
(7) |
where F gives the total transition flux by , πi is the stationary probability at state i, and is a committor probability, for i ∈ A, for i ∈ B, for i ∉ {A, B} [48, 51, 54, 55]. With the lag time divided by the minimum transition net flux, we obtained the time to travel from one set of states to the other. The minimum transition net flux, number of micro-states, and the estimated transition time in the shortest pathway between the ECD closed and open states are summarized in Table 1. The pathways connecting the closed states (G1, G2, and G3) are relatively short, but from the closed states to the open states (G4) it is rather remote, suggesting a clear partition in the conformational states. Regarding the minimum transition flux, the reversible transitions within the closed states are about 10–30 times faster than the transition from open states to a closed one. Key conformations in the shortest pathways among closed and open states are summarized in Fig. 5.
Table 1.
G1–G2 | G1–G3 | G2–G3 | G1–G4 | G2–G4 | G3–G4 | |
---|---|---|---|---|---|---|
Minimum net flux (10−5) | 6.10 | 7.17 | 7.84 | 0.41 | 0.26 | 0.59 |
Number of microstates | 3 | 5 | 3 | 13 | 12 | 11 |
Transition time (μs) | 27.6 | 23.4 | 21.4 | 412.3 | 650 | 284.5 |
Note: G1, G2, G3, and G4 are represented by one or two microstates
3. Conclusions
In summary, conformational ensembles with different roles in ligand binding and receptor activation can be discovered using long MD simulations. Using the dynamical network analysis, shared features can be revealed in conformational ensembles of variant ECD orientations, comparing with a ligand-bound state. With the construction of Markov State Model, the transition network kinetically connecting various GPCR ensembles can be identified. Overall, long MD simulations combined with these structural and kinetic analyses are useful tools to assess conformational transitions for the Class B GPCRs, based on which mechanistic insight can be gained to guide future designs of therapeutics to target these receptors.
4. Notes
In the MD simulations run by the program NAMD [56], we used the technology of Langevin dynamics [57] with a low damping coefficient of 1 ps−1 for the temperature control and the Nose-Hoover Langevin piston pressure control [58, 59] with a piston period of 0.05 ps and a piston decay time of 0.025 ps (default settings). In the microsecond-long MD simulations performed on the Anton supercomputer, Berendesn thermostat/barostat were applied for the NPT ensemble.
-
Examples of Execution (Modules may change according to different versions of MSMBuilder):
### building microstates
msmb KCenters --inp ‘trajectory_path/*.dcd’ --transformed kcenters_rmsd.h5 --metric
rmsd --top trajectory_path/ca.pdb --n_clusters 55 --random_state 1746
### building a transition matrix (in python interface)
from msmbuilder.dataset import dataset
from msmbuilder.cluster import KCenters
from msmbuilder.msm import MarkovStateModel
ds = dataset(‘kcenters_rmsd.h5’)
model = MarkovStateModel(lag_time=1, verbose=True).fit(ds)
for i in range(0, len(model.transform(ds))):
print i, len(model.transform(ds)[i])
sample = model.draw_samples(ds, 5)
###-scan implied_timescales---
tscale=[]
n=[]
for i in range(1, 50):
model = MarkovStateModel(lag_time=i, n_timescales=10, verbose=True).fit(ds)
n.append(model.n_states_)
tscale.append(model.timescales_)
### lumping microstates to macrostates
model.eigtransform(ds, right=True, mode=‘clip’)
model.eigenvalues_
### choose number of macrostates base on model.eigenvalues_ that are closed to 1.
from msmbuilder.lumping import PCCAPlus
pcca = PCCAPlus.from_msm(model, n_macrostates=4)
macro= pcca.microstate_mapping_
###-stationary population–
model = MarkovStateModel(lag_time=1, verbose=True).fit(ds)
mydict = {i:model.populations_[i] for i in range(0, model.n_states_)}
top_pi=sorted(mydict, key=mydict.__getitem__, reverse=True)
### key attributes for Chapman-Kolmogorov test
model.mapping_
model.populations_
model.countsmat_
model.transmat_
### find the first five shortest paths
from msmbuilder.tpt import net_fluxes
from msmbuilder.tpt import paths
netflux = net_fluxes(int, lst, model)
topN = paths(int, lst, net, num_paths=5)
commitor = committors(int, lst, model)
The last 1.5–2.5 μs of each microsecond simulation with stable final conformations were not included in building an MSM. A few trial tests showed that large population of final states caused the MSM to trim off the initial regions of less population and keep only some final states of large population to be most kinetically relevant.
Acknowledgements
Computational resources were provided by Anton (PSC, NIH P41GM103712-S1), Stampede (XSEDE, NSF ACI-1053575), and Vermont Advanced Computing Core (VACC). J.L. and V.M. thank the UVM REACH grant and the National Institutes of Health (NIH) under Award Number R01GM129431 for the funding support.
References
- 1.Katritch V, Cherezov V, Stevens RC (2013) Structure-function of the G protein–coupled receptor superfamily. Annu Rev Pharmacol Toxicol 53:531–556. 10.1146/annurev-pharmtox-032112-135923 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sakmar TP (2017) Introduction: G-protein coupled receptors. Chem Rev 117:1–3. 10.1021/acs.chemrev.6b00686 [DOI] [PubMed] [Google Scholar]
- 3.Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI (2012) Pharmacology and functions of receptors for vaso-active intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4–17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Culhane KJ, Liu Y, Cai Y, Yan EC (2015) Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors. Front Pharmacol 6:264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bortolato A, Dore AS, Hollenstein K, Tehan BG, Mason JS, Marshall FH (2014) Structure of Class B GPCRs: new horizons for drug discovery. Br J Pharmacol 171:3132–3145. 10.1111/bph.12689 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhang H, Qiao A, Yang D, Yang L, Dai A, de Graaf C, Reedtz-Runge S, Dharmarajan V, Zhang H, Han GW, Grant TD, Sierra RG, Weierstall U, Nelson G, Liu W, Wu Y, Ma L, Cai X, Lin G, Wu X, Geng Z, Dong Y, Song G, Griffin PR, Lau J, Cherezov V, Yang H, Hanson MA, Stevens RC, Zhao Q, Jiang H, Wang M-W, Wu B (2017) Structure of the full-length glucagon class B G-protein-coupled receptor. Nature 546:259–264. 10.1038/nature22363 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Doré AS, Weir M, Cooke RM, Marshall FH (2017) Crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature 546:254–258. https://doi.org/10.1038/nature22800 . https://doi.org/10.1038/nature22800http://www.nature.com/nature/journal/v546/n7657/abs/nature22800.html#supplementary-information. http://www.nature.com/nature/journal/v546/n7657/abs/nature22800.html#supplementary-information [DOI] [PubMed] [Google Scholar]
- 8.Zhang H, Qiao A, Yang L, Van Eps N, Frederiksen KS, Yang D, Dai A, Cai X, Zhang H, Yi C, Cao C, He L, Yang H, Lau J, Ernst OP, Hanson MA, Stevens RC, Wang MW, Reedtz-Runge S, Jiang H, Zhao Q, Wu B (2018) Structure of the glucagon receptor in complex with a glucagon analogue. Nature 553:106–110. 10.1038/nature25153 [DOI] [PubMed] [Google Scholar]
- 9.Hoare SRJ (2005) Mechanisms of peptide and nonpeptide ligand binding to class B G-protein coupled receptors. Drug Discov Today 10:417–427. 10.1016/S1359-6446(05)03370-2 [DOI] [PubMed] [Google Scholar]
- 10.Lappano R, Maggiolini M (2011) G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10:47–60 [DOI] [PubMed] [Google Scholar]
- 11.Millar RP, Newton CL (2010) The year in G protein-coupled receptor research. Mol Endocrinol 24:261–274. 10.1210/me.2009-0473 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lebon G, Warne T, Edwards PC, Bennett K, Langmead CJ, Leslie AGW, Tate CG (2011) Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation. Nature 474:521–525. 10.1038/nature10136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Li JN, Jonsson AL, Beuming T, Shelley JC, Voth GA (2013) Ligand-dependent activation and deactivation of the human adenosine A (2A) receptor. J Am Chem Soc 135:8749–8759. 10.1021/Ja404391q [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dror RO, Arlow DH, Maragakis P, Mildorf TJ, Pan AC, Xu HF, Borhani DW, Shaw DE (2011) Activation mechanism of the beta(2)-adrenergic receptor. Proc Natl Acad Sci U S A 108:18684–18689. 10.1073/Pnas.1110499108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yuan SG, Hu ZQ, Filipek S, Vogel H (2015) W246(6.48) opens a gate for a continuous intrinsic water pathway during activation of the adenosine A(2A) receptor. Angew Chem Int Ed 54:556–559. 10.1002/Anie.201409679 [DOI] [PubMed] [Google Scholar]
- 16.Liao C, Zhao X, Liu J, Schneebeli ST, Shelley JC, Li J (2017) Capturing the multiscale dynamics of membrane protein complexes with all-atom, mixed-resolution, and coarse-grained models. Phys Chem Chem Phys 19:9181–9188. 10.1039/C7CP00200A [DOI] [PubMed] [Google Scholar]
- 17.Liao C, Zhao X, Brewer M, May V, Li J (2017) Conformational transitions of the pituitary adenylate cyclase-activating polypeptide receptor, a human class B GPCR. Sci Rep 7:5427 10.1038/s41598-017-05815-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yang L, Yang D, de Graaf C, Moeller A, West GM, Dharmarajan V, Wang C, Siu FY, Song G, Reedtz-Runge S, Pascal BD, Wu B, Potter CS, Zhou H, Griffin PR, Carragher B, Yang H, Wang MW, Stevens RC, Jiang H (2015) Conformational states of the full-length glucagon receptor. Nat Commun 6:7859 10.1038/ncomms8859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kean J, Bortolato A, Hollenstein K, Marshall FH, Jazayeri A (2015) Conformational thermostabilisation of corticotropin releasing factor receptor 1. Sci Rep 5:11954 https://doi.org/10.1038/srep11954 . https://doi.org/10.1038/srep11954https://www.nature.com/articles/srep11954#supplementary-information. https://www.nature.com/articles/srep11954#supplementary-information [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu Z-J, Wang M-W, Stevens RC (2017) Human GLP-1 receptor trans-membrane domain structure in complex with allosteric modulators. Nature 546:312 10.1038/nature22378 [DOI] [PubMed] [Google Scholar]
- 21.Singh R, Ahalawat N, Murarka RK (2015) Activation of corticotropin-releasing factor 1 receptor: insights from molecular dynamics simulations. J Phys Chem B 119:2806–2817. 10.1021/Jp509814n [DOI] [PubMed] [Google Scholar]
- 22.Woolley MJ, Reynolds CA, Simms J, Walker CS, Mobarec JC, Garelja ML, Conner AC, Poyner DR, Hay DL (2017) Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs. Biochem Pharmacol 142:96–110. 10.1016/j.bcp.2017.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shaw DE, Dror RO, Salmon JK, Grossman JP, Mackenzie KM, Bank JA, Young C, Deneroff MM, Batson B, Bowers KJ, Chow E, Eastwood MP, Ierardi DJ, Klepeis JL, Kuskin JS, Larson RH, Lindorff-Larsen K, Maragakis P, Moraes MA, Piana S, Shan Y and Towles B (2009) Millisecond-scale molecular dynamics simulations on Anton Proceedings of the conference on high performance computing networking, storage and analysis, ACM, Portland, Oregon, pp. 1–11 [Google Scholar]
- 24.Voelz VA, Bowman GR, Beauchamp K, Pande VS (2010) Molecular simulation of ab initio protein folding for a millisecond folder NTL9 (1–39). J Am Chem Soc 132:1526 10.1021/ja9090353 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shelley MY, Selvan ME, Zhao J, Babin V, Liao C, Li J, Shelley JC (2017) A new mixed all-atom/coarse-grained model: application to melittin aggregation in aqueous solution. J Chem Theory Comput 13:3881–3897. 10.1021/acs.jctc.7b00071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liao C, Zhang Z, Kale J, Andrews DW, Lin J, Li J (2016) Conformational heterogeneity of bax helix 9 dimer for apoptotic pore formation. Sci Rep 6:29502 https://doi.org/10.1038/srep29502 . https://doi.org/10.1038/srep29502http://www.nature.com/articles/srep29502#supplementary-information. http://www.nature.com/articles/srep29502#supplementary-information [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Liao C, Selvan ME, Zhao J, Slimovitch JL, Schneebeli ST, Shelley M, Shelley JC, Li J (2015) Melittin aggregation in aqueous solutions: insight from molecular dynamics simulations. J Phys Chem B 119:10390–10398. 10.1021/acs.jpcb.5b03254 [DOI] [PubMed] [Google Scholar]
- 28.Best RB, Zhu X, Shim J, Lopes PEM, Mittal J, Feig M, MacKerell AD (2012) Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone ϕ, ψ and side-chain χ1 and χ2 dihedral angles. J Chem Theory Comput 8:3257–3273. 10.1021/ct300400x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Baker D, Agard DA (1994) Kinetics versus thermodynamics in protein folding. Biochemistry 33:7505–7509. 10.1021/bi00190a002 [DOI] [PubMed] [Google Scholar]
- 30.Earl DJ, Deem MW (2005) Parallel tempering: theory, applications, and new perspectives. Phys Chem Chem Phys 7:3910–3916 [DOI] [PubMed] [Google Scholar]
- 31.Zhang C, Ma JP (2010) Enhanced sampling and applications in protein folding in explicit solvent. J Chem Phys 132 10.1063/1.3435332.Artn244101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Martin HSC, Jha S, Coveney PV (2014) Comparative analysis of nucleotide translocation through protein nanopores using steered molecular dynamics and an adaptive biasing force. J Comput Chem 35:692–702. 10.1002/jcc.23525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hamelberg D, Mongan J, McCammon JA (2004) Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules. J Chem Phys 120:11919–11929. 10.1063/1.1755656 [DOI] [PubMed] [Google Scholar]
- 34.Pyrkosz AB, Eargle J, Sethi A, Luthey-Schulten Z (2010) Exit strategies for charged tRNA from GluRS. J Mol Biol 397:1350–1371. 10.1016/J.Jmb.2010.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Alexander RW, Eargle J, Luthey-Schulten Z (2010) Experimental and computational determination of tRNA dynamics. FEBS Lett 584:376–386. 10.1016/J.Febslet.2009.11.061 [DOI] [PubMed] [Google Scholar]
- 36.Sethi A, Eargle J, Black AA, Luthey-Schulten Z (2009) Dynamical networks in tRNA: protein complexes. Proc Natl Acad Sci U S A 106:6620–6625. 10.1073/Pnas.0810961106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph Model 14:33–38. 10.1016/0263-7855(96)00018-5 [DOI] [PubMed] [Google Scholar]
- 38.Glykos NM (2006) Software news and updates. Carma: a molecular dynamics analysis program. J Comput Chem 27:1765–1768. 10.1002/jcc.20482 [DOI] [PubMed] [Google Scholar]
- 39.Girvan M, Newman MEJ (2002) Community structure in social and biological networks. Proc Natl Acad Sci 99:7821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bowman GR, Huang XH, Pande VS (2009) Using generalized ensemble simulations and Markov state models to identify conformational states. Methods 49:197–201. 10.1016/j.ymeth.2009.04.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bowman GR, Beauchamp KA, Boxer G, Pande VS (2009) Progress and challenges in the automated construction of Markov state models for full protein systems. J Chem Phys 131:124101 10.1063/1.3216567 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Chodera JD, Singhal N, Pande VS, Dill KA, Swope WC (2007) Automatic discovery of metastable states for the construction of Markov models of macromolecular conformational dynamics. J Chem Phys 126:155101 10.1063/1.2714538.Artn155101 [DOI] [PubMed] [Google Scholar]
- 43.Chodera JD, Swope WC, Pitera JW, Dill KA (2006) Long-time protein folding dynamics from short-time molecular dynamics simulations. Multiscale Model Sim 5:1214–1226. 10.1137/06065146x [DOI] [Google Scholar]
- 44.Noé F, Fischer S (2008) Transition networks for modeling the kinetics of conformational change in macromolecules. Curr Opin Struct Biol 18:154–162. 10.1016/j.sbi.2008.01.008 [DOI] [PubMed] [Google Scholar]
- 45.Singhal N, Snow CD, Pande VS (2004) Using path sampling to build better Markovian state models: Predicting the folding rate and mechanism of a tryptophan zipper beta hairpin. J Chem Phys 121:415–425. 10.1063/1.1738647 [DOI] [PubMed] [Google Scholar]
- 46.Prinz JH, Wu H, Sarich M, Keller B, Senne M, Held M, Chodera JD, Schutte C, Noe F (2011) Markov models of molecular kinetics: generation and validation. J Chem Phys 134:174105 10.1063/1.3565032.Artn174105 [DOI] [PubMed] [Google Scholar]
- 47.Lane TJ, Bowman GR, Beauchamp K, Voelz VA, Pande VS (2011) Markov state model reveals folding and functional dynamics in ultra-long MD trajectories. J Am Chem Soc 133:18413–18419. 10.1021/ja207470h [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Noe F, Schutte C, Vanden-Eijnden E, Reich L, Weikl TR (2009) Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations. Proc Natl Acad Sci U S A 106:19011–19016. 10.1073/pnas.0905466106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Pande VS, Beauchamp K, Bowman GR (2010) Everything you wanted to know about Markov State Models but were afraid to ask. Methods 52:99–105. 10.1016/j.ymeth.2010.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Noe F, Horenko I, Schutte C, Smith JC (2007) Hierarchical analysis of conformational dynamics in biomolecules: transition networks of metastable states. J Chem Phys 126:155102 10.1063/1.2714539 [DOI] [PubMed] [Google Scholar]
- 51.Weinan E, Vanden-Eijnden E (2006) Towards a theory of transition paths. J Stat Phys 123:503–523. 10.1007/s10955-005-9003-9 [DOI] [Google Scholar]
- 52.Berezhkovskii A, Hummer G, Szabo A (2009) Reactive flux and folding pathways in network models of coarse-grained protein dynamics. J Chem Phys 130:205102 10.1063/1.3139063.Artn205102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Metzner P, Schutte C, Vanden-Eijnden E (2009) Transition path theory for Markov jump processes. Multiscale Mod Sim 7:1192–1219. 10.1137/070699500 [DOI] [Google Scholar]
- 54.Du R, Pande VS, Grosberg AY, Tanaka T, Shakhnovich ES (1998) On the transition coordinate for protein folding. J Chem Phys 108:334–350. 10.1063/1.475393 [DOI] [Google Scholar]
- 55.Bolhuis PG, Chandler D, Dellago C, Geissler PL (2002) Transition path sampling: throwing ropes over rough mountain passes, in the dark. Annu Rev Phys Chem 53:291–318. 10.1146/annurev.physchem.53.082301.113146 [DOI] [PubMed] [Google Scholar]
- 56.Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781–1802. 10.1002/jcc.20289 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Toda M, Kubo R, SaitM N, Hashitsume N (1991) Statistical physics II: nonequilibrium statistical mechanics. Springer Science & Business Media, Berlin [Google Scholar]
- 58.Martyna GJ, DJ T, Klein ML (1994) Constant-pressure molecular-dynamics algorithms. J Chem Phys 101:4177–4189. 10.1063/1.467468 [DOI] [Google Scholar]
- 59.Feller SE, Zhang YH, Pastor RW, Brooks BR (1995) Constant-pressure molecular-dynamics simulation - the Langevin piston method. J Chem Phys 103:4613–4621. 10.1063/1.470648 [DOI] [Google Scholar]